Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD

Respiratory Physiology and Neurobiology

Volumn 183, Issue 2, 2012, Pages 128-134

  Minet, Clémence ^a,b   Vivodtzev, Isabelle ^a,b   Tamisier, Renaud ^a,b   Arbib, François ^b   Wuyam, Bernard ^a,b   Timsit, Jean François ^b,c   Monneret, Denis ^a,b   Borel, Jean Christian ^a,b   Baguet, Jean Philippe ^b   Lévy, Patrick ^a,b   Pépin, Jean Louis ^a,b  

^a University Grenoble Alpes   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

Author keywords

COPD; Endothelial function; Fat free mass; Six minute walking distance; Systemic inflammation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BICARBONATE; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD CARBON DIOXIDE TENSION; BLOOD PRESSURE; BODY FAT DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HEART INFARCTION; HEART RATE; HUMAN; HYPERCAPNIA; HYPEREMIA; INFLAMMATION; LUNG FUNCTION; MALE; MULTIVARIATE ANALYSIS; MUSCLE FUNCTION; OXIDATIVE STRESS; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; WALKING;

AGED; BLOOD PRESSURE; BODY MASS INDEX; ENDOTHELIUM, VASCULAR; EXERCISE TEST; FEMALE; HUMANS; HYPERCAPNIA; HYPEREMIA; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; WALKING;

EID: 84864338952     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2012.06.017     Document Type: Article

References (33)

1. Anon. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic society and European Respiratory Society. American Journal of Respiratory and Critical Care Medicine 1999, 159:S1-S40.
2. Anon. ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 2002, 166:111-117.
3. Anon. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. Journal of Hypertension 2003, 21:1011-1053.
4. AlZadjali M.A., Godfrey V., Khan F., Choy A., Doney A.S., Wong A.K., Petrie J.R., Struthers A.D., Lang C.C. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. Journal of the American College of Cardiology 2009, 53:747-753.
5. Baldi S., Aquilani R., Domenico Pinna G., Poggi P., De Martini A., Bruschi C. Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia. International Journal of COPD 2010, 5:29-39.
6. Borel J.C., Roux-Lombard P., Tamisier R., Arnaud C., Monneret D., Arnol N., Baguet J.P., Levy P., Pepin J.L. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS One 2009, 4:e6733.
7. Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., Yates J.C., Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. New England Journal of Medicine 2007, 356:775-789.
8. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal 2004, 23:932-946.
9. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
10. Eagan T.M., Aukrust P., Ueland T., Hardie J.A., Johannessen A., Mollnes T.E., Damas J.K., Bakke P.S., Wagner P.D. Body composition and plasma levels of inflammatory biomarkers in COPD. European Respiratory Journal 2010, 36:1027-1033.
11. Eickhoff P., Valipour A., Kiss D., Schreder M., Cekici L., Geyer K., Kohansal R., Burghuber O.C. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2008, 178:1211-1218.
12. Fearon K.C., Voss A.C., Hustead D.S. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. American Journal of Clinical Nutrition 2006, 83:1345-1350.
13. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580.
14. Hamburg N.M., Keyes M.J., Larson M.G., Vasan R.S., Schnabel R., Pryde M.M., Mitchell G.F., Sheffy J., Vita J.A., Benjamin E.J. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008, 117:2467-2474.
15. Henriksen J.H., Christensen N.J., Kok-Jensen A., Christiansen I. Increased plasma noradrenaline concentration in patients with chronic obstructive lung disease: relation to haemodynamics and blood gases. Scandinavian Journal of Clinical and Laboratory Investigation 1980, 40:419-427.
16. Kingwell B.A., Sherrard B., Jennings G.L., Dart A.M. Four weeks of cycle training increases basal production of nitric oxide from the forearm. American Journal of Physiology 1997, 272:H1070-H1077.
17. Linke A., Erbs S., Hambrecht R. Effects of exercise training upon endothelial function in patients with cardiovascular disease. Frontiers in Bioscience 2008, 13:424-432.
18. Maki-Petaja K.M., Hall F.C., Booth A.D., Wallace S.M., Yasmin Bearcroft P.W., Harish S., Furlong A., McEniery C.M., Brown J., Wilkinson I.B. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 2006, 114:1185-1192.
19. Okamoto T., Masuhara M., Ikuta K. Effect of low-intensity resistance training on arterial function. European Journal of Applied Physiology 2011, 111:743-748.
20. Ozben B., Eryuksel E., Tanrikulu A.M., Papila-Topal N., Celikel T., Basaran Y. Acute exacerbation impairs endothelial function in patients with chronic obstructive pulmonary disease. Turk Kardiyoloji Dernegi Arsivi 2010, 38:1-7.
21. Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-2168.
22. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. Journal of Clinical Investigation 2003, 111:1805-1812.
23. Pitta F., Troosters T., Probst V.S., Spruit M.A., Decramer M., Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006, 129:536-544.
24. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. European Respiratory Journal: Supplement 1993, 16:5-40.
25. Rubinshtein R., Kuvin J.T., Soffler M., Lennon R.J., Lavi S., Nelson R.E., Pumper G.M., Lerman L.O., Lerman A. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. European Heart Journal 2010, 31:1142-1148.
26. Schutz Y., Kyle U.U., Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. International Journal of Obesity and Related Metabolic Disorders 2002, 26:953-960.
27. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Analytical Biochemistry 1968, 25:192-205.
28. Serres I., Gautier V., Varray A., Prefaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 1998, 113:900-905.
29. Steiner M.C., Barton R.L., Singh S.J., Morgan M.D. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. European Respiratory Journal 2002, 19:626-631.
30. Verma S., Wang C.H., Li S.H., Dumont A.S., Fedak P.W., Badiwala M.V., Dhillon B., Weisel R.D., Li R.K., Mickle D.A., Stewart D.J. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002, 106:913-919.
31. Vestbo J., Prescott E., Almdal T., Dahl M., Nordestgaard B.G., Andersen T., Sorensen T.I., Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. American Journal of Respiratory and Critical Care Medicine 2006, 173:79-83.
32. Vivodtzev I., Minet C., Wuyam B., Borel J.C., Vottero G., Monneret D., Baguet J.P., Levy P., Pepin J.L. Significant improvement in arterial stiffness after endurance training in patients with COPD. Chest 2010, 137:585-592.
33. Zwaka T.P., Hombach V., Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001, 103:1194-1197.